PRSNF yields 166.17% · PFE yields 6.20%● Live data
📍 PRSNF pulled ahead of the other in Year 1
Combined, PRSNF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of PRSNF + PFE for your $10,000?
Keeks Social Inc. provides live streaming social media products and services consumers and businesses. The company focuses on offering social commerce enabled products that allow for a monetizable user experience to various users, consumers, and businesses. It also provides web-based products, including mobile applications that are complete with enterprise grade ecommerce infrastructure, such as multi-currency, multi-lingual, and turnkey mobile commerce suites for users. In addition, the company offers Peeks Social Platform, a social commerce enabled livestreaming platform; Keek Social, a web and app based platform that provides users the chance to share their lives and connect with others through short-form and long-form videos; and Keek Social video sharing app, an AI powered video sharing network that allows to get famous fast by the use of Fire Posts. It operates in Canada, the United States, Africa, the Middle East, India, Europe, and internationally. The company was formerly known as Personas Social Incorporated and changed its name to Keeks Social Inc. in October 2025. Keeks Social Inc. is headquartered in Toronto, Canada.
Full PRSNF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.